JIMSMENews

Follow us : Mail

Standalone profit reached Rs.40.32 lacs at Vanta Bioscience in HY31.03.2020


Vanta Bioscience announced standalone and consolidated financial results for half year ended March 2020 showing Rs.0.24 lacs rise in net standalone profit compared to a year ago period.

Company : Vivid Mercantile Ltd

Vanta Bioscience recently release the financial results for the second half of financial year 2019-20 marking a standalone revenue of Rs.6.92 crore against Rs.6.55 crorein a year ago period.

Standalone EPS was Rs.0.64 in HY2 of FY19-20 whereas last year same period it was Rs.0.77.

In the financial year concluded 31st March 2020, the company earned standalone revenue of Rs.14.22 crore with PBT of Rs.1.28 crore and PAT of Rs.97.80 lacs.

Consolidated financial data for HY2 of FY2019-20 at Vanta Bioscience is given below:

• Revenue reached Rs.6.92 crore against Rs.6.61 crore in a year ago period.

• PBT stands at Rs.54.56 lacs against Rs.64.30 lacs in the preceding year corresponding period.

• PAT is Rs.46.05 lacs whereas last year same period it was Rs.40.36 lacs

• EPS is Rs.0.73whereas previous year same period it was Rs.0.78.

The total consolidated earnings at Vanta Bioscience in the financial year 2019-20 was Rs.14.25 crore marking a pre-tax profit of Rs.1.34crore and profit after tax was over Rs.1 crore.


Recent Stories

Weekly Journal

Get weekly updates on latest SME news in your e-mail.


Weekly Journal
Get weekly updates on latest SME news in your e-mail.
Terms of Use |Privacy Policy
Copyright © 2019 JimSMEnews. The JimSMEnews is not responsible for the content of external sites. Read about our approach to external linking.